Karl Hård
Investor Relations Contact at EGETIS THERAPEUTICS AB
Karl Hård active positions
| Companies | Position | Start | End |
|---|---|---|---|
| EGETIS THERAPEUTICS AB | Investor Relations Contact | 31/01/2022 | - |
| Public Communications Contact | 31/01/2022 | - |
Career history of Karl Hård
Former positions of Karl Hård
| Companies | Position | Start | End |
|---|---|---|---|
| KIADIS PHARMA N.V. | Investor Relations Contact | 04/09/2017 | 30/12/2018 |
| Public Communications Contact | 04/09/2017 | 30/12/2018 | |
| REDX PHARMA PLC | Investor Relations Contact | 07/09/2016 | 01/07/2017 |
| Public Communications Contact | 07/09/2016 | 01/07/2017 | |
| University of Leiden | Corporate Officer/Principal | - | - |
| ASTRAZENECA PLC | Public Communications Contact | - | - |
Training of Karl Hård
| University of Utrecht | Doctorate Degree |
| University of Helsinki | Graduate Degree |
Statistics
International
| Netherlands | 4 |
| United Kingdom | 3 |
| Finland | 2 |
Operational
| Public Communications Contact | 4 |
| Investor Relations Contact | 3 |
| Doctorate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 4 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 3 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| REDX PHARMA PLC | Health Technology |
| EGETIS THERAPEUTICS AB | Health Technology |
| Private companies | 1 |
|---|---|
Kiadis Pharma NV
 Kiadis Pharma NV Pharmaceuticals: MajorHealth Technology Kiadis Pharma NV engages in pharmaceutical development of cell-based immunotherapy products in the field of diseases of the blood building system. Its lead product is the ATIR101. The company was founded in 1997 and is headquartered in Amsterdam, the Netherlands. | Health Technology |
- Stock Market
- Insiders
- Karl Hård
- Experience
